CHO cells: a staple of recombinant antibody production
25 August, 2022Recombinant antibody expert Desmond Schofield reveals the astonishing abilities of CHO cells and some of their most interesting characteristics.
New biosynthesis method for producing antibiotics
23 August, 2022Researchers fluorinated a natural antibiotic via targeted bioengineering — a method through which an entire substance class of medically relevant natural products can be modified.
Epidural nerve block helps treat psoriasis
22 August, 2022A proof-of-concept pilot study highlights the potential for epidural lidocaine injection as an effective and safe therapeutic strategy for psoriasis treatment.
Moderna to build mRNA manufacturing plant at Monash
16 August, 2022The state-of-the-art facility, which is expected to produce up to 100 million mRNA respiratory vaccine doses annually, will be located at Monash's campus in Clayton.
Calling all RNA biotechs — let's collaborate
15 August, 2022ATA Scientific is helping Australia build a world-class RNA science-based biotech industry.
CSIRO's 'missing link' lab to develop Aus vaccine pipeline
15 August, 2022Researchers at the National Vaccine and Therapeutics Lab will turn vaccine and drug candidates into products that can be manufactured in large quantities for clinical trials.
Nanowires accelerate stem cells' transition into bone
25 July, 2022Bone-forming stem cells grown on a mesh of these nanowires transform into mature bone much faster than is typical of other culturing conditions.
Diabetes drug to correct metabolic abnormalities
22 July, 2022PATAS, part of a new class of antidiabetic drugs, can correct the metabolic abnormalities leading to type 2 diabetes and its associated comorbidities.
Spider venom treatment for heart attacks progressing to trials
07 July, 2022The drug candidate uses a molecule found in the venom of the K’gari funnel-web spider, and can potentially prevent damage caused by heart attacks and stroke.
Existing drug may help treat spinal cord injury
17 June, 2022Scientists have shown that an existing drug may reduce damage after spinal cord injury (SCI), by blocking the inflammatory response in the spinal cord.
Human ear reconstructed with 3D-bioprinted implant
08 June, 2022AuriNovo is a patient-specific, living tissue implant created using 3D-bioprinting technology for surgical reconstruction of the outer ear in people born with microtia.
Damaged liver repaired, transplanted after 3 days outside body
06 June, 2022Liver4Life reports the successful treatment of a damaged human liver for three days outside of the body, with implantation of the recovered organ into a cancer patient.
Wireless neurostimulator like a pacemaker for the brain
24 May, 2022Neurological disorders like Parkinson's, chronic depression and other psychiatric conditions can now be managed at home.
Bringing clinical trials to the home: a game changer for the sector
23 May, 2022 by Edwin Ng, Senior Vice-President, Asia-Pacific for Medidata, a Dassault Systèmes companyCOVID-19 has forced Australia's pharmaceutical and healthcare companies to completely redesign how clinical trials are run.
How do antidepressants treat nerve pain?
04 May, 2022Knowing how pain impulses are inhibited by tricyclic antidepressants is expected to lead to new and improved treatment options.
